An eight-day trial and two-hour jury deliberation has culminated in the conviction of Pennsylvania cardiologist Samirkumar J. Shah, who on June 14 was found guilty of two counts of healthcare fraud for falsely billing insurers for unnecessary angina treatments.

Eli Lilly stocks are down 1.4% in premarket trading this week after the company announced the results of its long-awaited REWIND study, Barron’s reported.

The American College of Cardiology is partnering with Chicago-based company Veradigm to assemble the largest-ever ambulatory chronic disease network in the U.S., comprising more than 250,000 clinicians and 100 million patients.

An updated cost-effectiveness analysis of evolocumab suggests that while treatment with the PCSK9 inhibitor may always be somewhat costly, it remains effective in hard-to-treat patients and its reduced list price meets cost-effectiveness thresholds across a range of CV events in patients with very-high-risk atherosclerotic CVD.

Prompted by a New York Times deep-dive into elevated death rates at North Carolina Children’s Hospital, North Carolina’s secretary of health on May 31 called for an investigation into the hospital’s pediatric heart surgery unit.

A seven-years long whistleblower lawsuit against Kansas cardiologist Joseph Galichia ended May 30 with a $5.8 million settlement, the Wichita Eagle reported.

The atrial fibrillation market is projected to reach $14.68 billion by 2026, according to recent estimates from market research company Reports and Data.

An undocumented immigrant living in Brooklyn, N.Y., was deported to his home country last Wednesday after ICE officials ignored attorneys’ requests to keep him in the U.S. for much-needed medical treatment, WNYC reported.